Eduardo Franco

(Peer-reviewed articles) [(*) corresponding author, (§) denotes a student of mine as first author]

1. Franco EL(*), Souza AVR. Experimental S. mansoni infection in mice: Blood white cells, serum proteins, glycemia, and blood urea in various stages of the infection. Revista do Instituto de Medicina Tropical de Sao Paulo, 21: 161-165, 1979.

2. Franco EL(*), Duarte EF, Souza AVR, Corsini AC. A quantitative method for determining Toxoplasma gondii, white cells, and the volume of ascitic fluid in experimentally infected mice. Journal of Parasitology 66: 852-853, 1980.

3. Franco EL(*), Sulzer AJ, Higby RW, Peralta JM. Immunoglobulin G and immunoglobulin M polar staining of Toxoplasma gondii in the indirect immunofluorescence test. Journal of Clinical Microbiology 12: 780-784, 1980.

4. Franco EL(*), Walls KW, Sulzer AJ. Reverse enzyme immunoassay for detection of specific anti-Toxoplasma immunoglobulin M antibodies. Journal of Clinical Microbiology 13: 859-864, 1981.

5. Walls KW(*), Franco EL. Reversed enzyme immunoassay. Lyon Medical 248 (suppl.): 43-49, 1982.

6. Franco EL(*), Sulzer AJ. Indirect immunofluorescence test for antimalarial antibodies: influence of temperature, time of incubation, and presence of cell monolayers on the antigenic characteristics of Plasmodium falciparum matured “in vitro”. Revista do Instituto de Medicina Tropical de Sao Paulo 25: 229-235, 1983.

7. Franco EL(*), Walls KW, Sulzer AJ, Soto JC. Diagnosis of acute acquired toxoplasmosis with the enzyme-labelled antigen reversed immunoassay for immunoglobulin M antibodies. Journal of Immunoassay 4: 373-393, 1983.

8. Bradley LA, Franco EL, Reisner HM(*). Use of monoclonal antibodies in an enzyme immunoassay for factor VIII-related antigen. Clinical Chemistry 30: 87-92, 1984.

9. Franco EL(*), Walls KW, Sulzer AJ, Campbell GH, Roberts JM. Computer-assisted multiple categorization of absorbance values in ELISA through pictorial emulation of 96-well plates. Journal of Immunological Methods 70: 45-52, 1984.

10. Campbell GH(*), Miller LH, Hudson D, Franco EL, Andrysiak PM. Monoclonal antibody characterization of Plasmodium falciparum antigens. American Journal of Tropical Medicine and Hygiene 33: 1051-1054, 1984.

11. Franco EL. Immunoserology of Malaria. Revista do Instituto de Medicina Tropical de Sao Paulo 28: 111-125, 1986.

12. Sulzer AJ(*), Franco EL, Takafuji E, Benenson M, Walls KW, Greenup RL. An oocyst-transmitted outbreak of toxoplasmosis: patterns of immunoglobulin G and M over one year. American Journal of Tropical Medicine and Hygiene 35: 290-296, 1986.

13. Guimaraes MCS(*), Celeste BJ, Franco EL. Evaluation of Dot enzyme-linked immunosorbent assay for mucocutaneous leishmaniasis and comparison with microplate enzyme-immunoassay. Journal of Clinical Microbiology 24: 364-367, 1986.

14. Franco EL(*), Simons AR. Simple algorithms for the representation of deterministic and stochastic versions of the Reed-Frost epidemic model using a programmable calculator. American Journal of Epidemiology 123: 905-915, 1986.

15. Possik RA(§), Franco EL(*), Pires DR, Wohnrath DR, Ferreira EB. Sensitivity, specificity, and predictive value of laparoscopy for the staging of gastric cancer and for the detection of liver metastases. Cancer 58: 1-6, 1986.

16. Pacheco MM, Oshima CT, Lopes MP, Widman A, Franco EL(*), Brentani MM. Steroid hormone receptors in male breast diseases. AntiCancer Research 6: 1013-1018, 1986.

17. Brentani MM, Franco EL(*), Oshima CT, Pacheco MM. Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: A multivariate analysis approach. International Journal of Cancer 38: 637-642, 1986.

18. Franco EL. A monoclonal antibody-based enzyme immunoassay to detect specificities in malarial antisera: A preliminary report. Memorias do Instituto Oswaldo Cruz 81: 229-230, 1986.

19. Camargo B(§), Andrea ML, Franco EL(*). Catching up with history: Treatment of Wilms’ tumor in a developing country. Medical and Pediatric Oncology 15: 270-276, 1987.

20. Franco EL. Epidemiology of cancers of the upper respiratory and digestive system. Revista Brasileira Cirurgia de Cabeca e Pescoco 11: 23-33, 1987.

21. Franco EL(*), Campos-Filho N, Villa LL, Torloni H. Correlation patterns of cancer relative frequencies with some socioeconomic and demographic indicators in Brazil: An ecologic study. International Journal of Cancer 41: 24-29, 1988.

22. Andrea ML, Camargo B, Alves AC, Franco EL(*). Factors of prognostic importance in childhood non-Hodgkin's lymphoma treated with two modified LSA2-L2 protocols: A multivariate analysis approach. Cancer 62: 240-250, 1988.

23. Pacheco MM, Brentani MM, Franco EL(*), Fontelles JA, Chamone DF, Marques LA. Plasminogen activator expression and steroid hormone receptors in female breast cancer: A multifactorial study. International Journal of Cancer 41: 798-804, 1988.

24. Campos-Filho N, Franco EL(*). Microcomputer-assisted univariate survival data analysis using Kaplan-Meier life table estimators. Computer Methods and Programs in Biomedicine 27: 223-228, 1988.

25. Campos-Filho N, Franco EL(*). A microcomputer program for multiple logistic regression by unconditional and conditional maximum likelihood methods. American Journal of Epidemiology 129: 439-444, 1989.

26. Villa LL, Franco EL(*). Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil. Journal of the National Cancer Institute 81: 332-340, 1989.

27. Zacharias DPM, Franco EL(*), Monteiro J, Maciel MS, Regazzini R, Calvis LA, Abranches ID, Belfort FA, Bandiera DC. Chemotherapy of disseminated melanoma with bleomycin, vincristine, CCNU, and DTIC (BOLD regimen). Cancer 63: 1676-1680, 1989.

28. Franco EL(*), Kowalski LP, Oliveira BV, Curado MP, Pereira RN, Silva ME, Fava AS, Torloni H. Risk factors for oral cancer in Brazil: A case-control study. International Journal of Cancer 43: 992-1000, 1989.

29. Erwenne CM(§), Franco EL(*). Age and lateness of referral as determinants of extra-ocular retinoblastoma. Ophthalmic Paediatrics and Genetics 10: 179-184, 1989.

30. Del Giglio A(§), Franco EL(*), Torloni H, Marques LA, Brentani MM, Arap W, Macchione M, Chammas R. Tumor and serum beta-2 microglobulin expression in women with breast cancer. American Journal of Clinical Pathology 92: 339-342, 1989.

31. Guimaraes MCS(*), Celeste BJ, Franco EL, Cuce LC, Belda W. Evaluation of serological diagnostic indices for mucocutaneous leishmaniasis: Immunofluorescence tests and enzyme-linked immunoassays for IgG, IgM, and IgA antibodies. Bulletin of the World Health Organization 67: 643-648, 1989.

32. Marques LA(§), Franco EL, Brentani RR(*), Torloni H, Brentani MM, Silva-Neto JB. Independent prognostic value of laminin receptor expression in breast cancer survival. Cancer Research 50: 1479-1483, 1990.

33. Campos-Filho N, Franco EL(*). Microcomputer-assisted multivariate survival data analysis using Cox's proportional hazards regression model. Computer Methods and Programs in Biomedicine 31: 81-87, 1990.

34. Guimaraes MCS(*), Celeste BJ, Franco EL. Diagnostic performance indices for immunofluorescent tests and enzyme immunoassays of leishmaniasis sera from Northern and North-eastern Brazil. Bulletin of the World Health Organization 68: 39-43, 1990.

35. Soto JC(*), Levy M, Allard R, Franco EL. Le SIDA et le contrôle des infections au Québec: étude des attitudes, des connaisances et des comportements des intervenants en santé dentaire. J. Santé Dent. Comm. Québec 3: 5-11, 1990.

36. Franco EL. The sexually-transmitted disease model for cervical cancer: Incoherent epidemiologic findings and the role of misclassification of human Papillomavirus infection. Epidemiology 2: 98-106, 1991.

37. Camargo B(§), Franco EL(*). Single-dose versus fractionated-dose dactinomycin in the treatment of Wilms’ tumor: Preliminary results of a clinical trial. Cancer 67: 2990-2996, 1991.

38. Payment P(*), Richardson L, Siemiatycki J, Dewar R, Edwardes M, Franco EL. A randomized trial to evaluate the risk of gastrointestinal disease due to consumption of drinking water meeting current microbiological standards. American Journal of Public Health 81: 703-708, 1991.

39. Payment P(*), Franco EL, Richardson L, Siemiatycki J. Gastrointestinal health effects associated with the consumption of drinking water produced by point-of-use domestic reverse-osmosis filtration units. Applied and Environmental Microbiology 57: 945-948, 1991.

40. Franco EL(*), Kowalski LP, Kanda JL. Risk factors for second cancers of the upper respiratory and digestive systems: a case-control study. Journal of Clinical Epidemiology 44: 615-625, 1991.

41. Franco EL(*), Kowalski LP. Design options for the study of second cancers. Journal of Clinical Epidemiology 44: 629-632, 1991.

42. Petrilli AS(*§), Gentil F, Epelman S, Lopes LF, Bianchi A, Lopes A, Figueiredo M, Marques E, Consentino E, Prospero D, Camargo OP, Oliveira NR, Franco EL, Jaffe N. Increased survival, limb preservation, and prognostic factors for osteosarcoma. Cancer 68: 733-737, 1991.

43. Franco EL(*), Camargo B, Saba L, Marques LA. Epidemiological and clinical correlations with genetic characteristics of Wilms' tumor: Results of the Brazilian Wilms’ Tumor Study Group. International Journal of Cancer 48: 641-646, 1991.

44. Franco EL. Multiple cancers of the upper aero-digestive tract: The challenge of risk factor identification. Cancer Letters 60: 1-8, 1991.

45. Franco EL. Viral etiology of cervical cancer: A critique of the evidence. Reviews of Infectious Diseases 13: 1195-1206, 1991.

46. Kowalski LP(*§), Franco EL, Andrade J, Oliveira BV, Pontes PL. Prognostic factors in laryngeal cancer patients submitted to surgical treatment. Journal of Surgical Oncology 48: 87-95, 1991.

47. Franco EL. Prognostic value of human Papillomavirus in the survival of cervical cancer patients: An overview of the evidence. Cancer Epidemiology, Biomarkers & Prevention 1: 499-504, 1992.

48. Franco EL. Human Papillomavirus and the natural history of cervical cancer. Infections in Medicine 10: 57-64, 1993.

49. Franco EL(*), Dib LL, Pinto DS, Lombardo V, Contesini H. Race and gender influences on the survival of patients with mouth cancer. Journal of Clinical Epidemiology 46: 37-46, 1993.

50. Payment P(*), Franco EL, Siemiatycki J. Absence of relationship between health effects due to tap water consumption and drinking water quality parameters. Water Science and Technology 27: 3-4, 1993.

51. Marques LA(§), Franco EL(*). Association between timing of surgery during menstrual cycle and prognosis in pre-menopausal breast cancer. International Journal of Cancer 53: 707-708, 1993.

52. Soto JC(*), Levy M, Allard R, Franco EL. Determinants of AIDS preventive behaviour among dental professionals. Canadian Journal of Public Health 84: 128-131, 1993.

53. Rapoport A(*§), Franco EL. Prognostic factors and relative risk in hypopharyngeal cancer - Related parameters concerning stage, therapeutics, and evolution. Sao Paulo Medical Journal 111: 337-343, 1993.

54. Payment P(*), Franco EL. Clostridium perfringens and somatic coliphages as indicators of the efficiency of drinking water treatment for viruses and protozoan cysts. Applied and Environmental Microbiology 59: 2418-2424, 1993.

55. Coelho FRG(*§), Kowalski LP, Franco EL, Contesini H, Zeferino LC. Analise de sobrevida de uma amostra de 2000 casos de cancer tratados no Hospital A.C. Camargo de 1980 a 1987. Acta Oncologica Brasileira 13: 8-16, 1993.

56. Siemiatycki J(*), Dewar R, Desy M, Krewski D, Franco E, Richardson L. Are the apparent effects of cigarette smoking on lung and bladder cancers due to uncontrolled confounding by occupational exposures? Epidemiology 5: 57-65, 1994.

57. Chammas R(*), Cella N, Marques LA, Brentani RR, Hynes NE, Franco EL. B1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Research 54: 306-307, 1994.

58. Kowalski LP(*§), Franco EL, Fava AS, Andrade J, Oliveira BV, Curado MP, Torloni H. Lateness of diagnosis of oral and oropharyngeal carcinoma: Factors related to the tumour, the patient, and health professionals. European Journal of Cancer (Part B: Oral Oncology) 30B: 167-173, 1994.

59. Camargo B(§), Franco EL(*). A randomized clinical trial of single-dose versus fractionated-dose dactinomycin in the treatment of Wilms’ tumor: Results after extended follow-up. Cancer 73: 3081-3086, 1994.

60. Franco EL. Cancer epidemiology: substance and methods (invited review). Journal of the Brazilian Association for the Advancement of Science (Ciencia e Cultura) 46: 46-62, 1994.

61. Pintos J(§), Franco EL(*), Oliveira BV, Kowalski LP, Curado MP, Dewar R. Maté, coffee, and tea consumption and risk of cancers of the upper aerodigestive tract in Southern Brazil. Epidemiology 5: 583-590, 1994.

62. Payment P(*), Franco EL, Fout S. Incidence of Norwalk virus infections during a prospective epidemiological study of drinking water related gastrointestinal illness. Canadian Journal of Microbiology 40: 805-809, 1994.

63. Franco E(*), Villa LL, Rahal P, Ruiz A. Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection. Journal of the National Cancer Institute 86: 1558-1559, 1994.

64. Sharpe C(§), Franco E(*), Camargo B, Lopes L, Barreto J, Johnsson R, Mauad M. Parental exposures to pesticides and risk of Wilms' tumor in Brazil. American Journal of Epidemiology 141: 210-217, 1995.

65. Ferenczy A(*), Choukroun D, Falcone T, Franco EL. The effect of cervical loop electrosurgical excision on subsequent pregnancy outcome: North-American experience. American Journal of Obstetrics & Gynecology 172: 1246-1250, 1995.

66. Franco EL. Editorial: Cancer causes revisited: Human papillomavirus and cervical neoplasia. Journal of the National Cancer Institute 87: 779-780, 1995. (peer-reviewed)

67. Franco EL(*), Villa LL, Ruiz A, Costa MC. Transmission of cervical human papillomavirus infection by sexual activity: Differences between low and high oncogenic risk types. Journal of Infectious Diseases 172: 756-763, 1995.

68. Siemiatycki J(*), Krewski D, Franco E, Kaiserman M. Associations between cigarette smoking and each of 21 types of cancer: A multi-site case-control study. International Journal of Epidemiology 24: 504-514, 1995.

69. Kowalski LP(*§), Franco EL, Andrade J. Factors influencing regional lymph node metastasis from laryngeal carcinoma. Annals of Otology, Rhinology & Laryngology 104: 442-447, 1995.

70. Foulkes WD, Brunet JS, Kowalski LP, Narod SA, Franco EL(*). Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study. International Journal of Cancer 63: 769-773, 1995.

71. Sharpe CR(§), Franco EL(*). Etiology of Wilms' tumor. Epidemiologic Reviews 17: 415-432, 1995.

72. Franco E(*), Bergeron J, Villa L, Arella M, Richardson L, Arseneau J, Stanimir G. Human papillomavirus DNA in invasive cervical carcinomas and its association with patient survival: a nested case-control study. Cancer Epidemiology, Biomarkers & Prevention 5: 271-275, 1996.

73. Franco EL. Mechanistic reasoning in socio-behavioral epidemiology: The influence of race and ethnicity on cancer survival. Epidemiology 7: 326-327, 1996.

74. Sharpe C(§), Franco E(*). Use of dipyrone during pregnancy and risk of Wilms' tumor. Epidemiology 7: 533-535, 1996.

75. Ferenczy A(*), Franco E, Arseneau J, Wright T, Richart R. Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study. American Journal of Obstetrics & Gynecology 175: 651-656, 1996.

76. Ferenczy A(*), Robitaille J, Franco E, Arseneau J, Richart R, Wright T. Conventional cervical cytologic smears vs ThinPrep smears: A paired comparison study on cervical cytology. Acta Cytologica 40: 1136-1142, 1996.

77. Payment P(*), Siemiatycki J, Richardson L, Renaud G, Franco E, Prevost M. A prospective epidemiological study of gastrointestinal health effects due to the consumption of drinking water. International Journal of Environmental Health Research 7: 5-31, 1997.

78. Ferenczy A(*), Gelfand M, Franco E, Mansour N. Human papillomavirus infection in postmenopausal women with and without hormone therapy. Obstetrics and Gynecology 90: 7-11, 1997.

79. Coelho FR(*§), Franco EL, Kowalski LP, Zeferino LC, Brentani MM, Abrão FS. Carcinoma espinocelular do colo uterino submetido a cirurgia radical isolada ou em combinação com radioterapia: Análise multivariada de fatores prognósticos. Acta Oncologica Brasileira 17: 68-87, 1997.

80. Coutlée F(*), Mayrand M, Provencher D, Franco E. The future of hpv testing in clinical laboratories and applied virology research. Clinical and Diagnostic Virology 8: 123-141, 1997.

81. Mandeville R(*), Franco E, Ghali S, Nadon L, Rocheleau N, Mercier G, Désy M, Gaboury L. Evaluation of the potential carcinogenicity of 60 Hz linear sinusoidal continuous-wave magnetic fields in Fischer F344 rats. FASEB Journal 11: 1127-1136, 1997.

82. Bruneau J(*§), Lamothe F, Franco E, Lachance N, Désy M, Soto J, Vincelette J. High rates of HIV-1 infection among drug users participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology 146: 994-1002, 1997.

83. Bruneau J(*§), Franco E, Lamothe F. Assessing harm reduction strategies: The dilemma of observational studies. American Journal of Epidemiology 146: 1007-1010, 1997.

84. Allison P(§), Franco E, Feine J(*). Predictors of professional diagnostic delays for upper aerodigestive tract carcinoma. European Journal of Cancer (Part B: Oral Oncology) 34:127-132, 1998.

85. Allison P(§), Franco E, Black M, Feine J(*). The role of professional diagnostic delays in the prognosis of upper aerodigestive tract carcinoma. European Journal of Cancer (Part B: Oral Oncology) 34: 147-153, 1998.

86. Velly AM(§), Franco EL(*), Schlecht N, Pintos J, Kowalski LP, Oliveira BV, Curado MP. Relationship between dental factors and risk of upper aero-digestive tract cancer. European Journal of Cancer (Part B: Oral Oncology) 34: 284-291, 1998.

87. Nguyen TN(§), Bourdeau JL, Ferenczy A(*), Franco EL. Clinical significance of histiocytes in the detection of endometrial adenocarcinoma and hyperplasia. Diagnostic Cytopathology 19: 89-93, 1998.

88. Pintos J(§), Franco EL(*), Kowalski LP, Oliveira BV, Curado MP. Use of wood stoves and risk of cancers of the upper aero-digestive tract: a case-control study. International Journal of Epidemiology 27: 936-940, 1998.

89. Coelho FR(§*), Franco EL, Kowalski LP, Abrao FS. Preoperative irradiation therapy and radical hysterectomy: prognostic value of tumor regression after initial irradiation of squamous cell carcinoma of the cervix. Sao Paulo Medical Journal (Revista Paulista de Medicina). 116: 1700-1709, 1998.

90. Franco EL(*), Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. Journal of the National Cancer Institute 91: 506-511, 1999.

91. Pintos J(§), Franco EL(*), Bergeron J, Arella M, Black M. Human papillomavirus and prognoses of patients with cancers of the upper aero-digestive tract. Cancer 85: 1903-1909, 1999.

92. Sharpe C(§), Franco E(*), Camargo B, Lopes L, Barreto J, Johnsson R, Mauad M. The influence of parental age on the risk of Wilms’ tumor. Paediatric & Perinatal Epidemiology 13:138-143, 1999.

93. Coutlée F(*), Gravitt P, Richardson H, Hankins C, Franco E, Lapointe N, Voyer H. Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay. Journal of Clinical Microbiology 37: 1852-1857, 1999.

94. Schlecht N(§), Franco EL(*), Pintos J, Kowalski LP. Effect of smoking cessation and tobacco type on the risk of cancers of the upper aero-digestive tract in Brazil. Epidemiology 10: 412-418, 1999.

95. Franco EL(*), Ferenczy A. Assessing gains in diagnostic utility when human papillomavirus testing is used as a Pap smear adjunct for triaging women with cervical cytological abnormalities. American Journal of Obstetrics & Gynecology 181: 382-386, 1999.

96. Franco EL(*), Villa LL, Sobrinho J, Prado JM, Rousseau MC, Désy M, Rohan TE. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high risk area for cervical cancer. Journal of Infectious Diseases 180: 1415-1423, 1999.

97. Franco E(*), Villa L, Rohan T, Ferenczy A, Petzl-Erler M, Matlashewski G. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Pan American Journal of Public Health 6: 223-233, 1999.

98. Schlecht N(§), Franco EL(*), Pintos J, Negassa A, Kowalski LP, Oliveira BV, Curado MP. Interaction between tobacco and alcohol consumption on the risk of cancers of the upper aero-digestive tract in Brazil. American Journal of Epidemiology 150: 1129-1137, 1999.

99. Mandeville R(*), Franco E, Sidrac-Ghali S, Paris-Nadon L, Rocheleau N, Mercier G, Desy M, Devaux C, Gaboury L. Evaluation of the potential promoting effect of 60 Hz magnetic fields on N-ethyl-N-nitrosourea induced neurogenic tumors in female F344 rats. Bioelectromagnetics 21: 84-93, 2000.

100. Richardson H(§), Franco E(*), Pintos J, Bergeron J, Arella M, Tellier P. Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal University students. Sexually Transmitted Diseases 27: 79-86, 2000.

101. Rousseau MC(§), Franco EL(*), Villa LL, Sobrinho J, Termini L, Prado JM, Rohan TE. A cumulative case-control study of risk factor profiles for oncogenic and non-oncogenic cervical human papillomavirus infections. Cancer Epidemiology, Biomarkers & Prevention 9: 469-476, 2000.

102. Makni H(§), Franco E(*), Kaiano J, Villa L, Lebrecque S, Dudley R, Storey A, Matlashewski G. P53 polymorphism in codon 72 and risk of HPV-induced cervical cancer: effect of inter-laboratory variation. International Journal of Cancer 87: 528-533, 2000.

103. Klam S(§), Arseneau J, Mansour N, Franco E, Ferenczy A(*). Comparison of endocervical curettage and endocervical brushing. Obstetrics & Gynecology 96: 90-94, 2000.

104. Ratnam S, Franco EL(*), Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiology, Biomarkers & Prevention 9, 945-951, 2000.

105. Brogly SB(§), Bruneau J(§*), Lamothe F, Vincelette J, Franco EL. Risk behaviour change and HIV infection among injection drug users in Montreal. AIDS 14: 2575-2582, 2000.

106. Maciag PC(§), Schlecht NF, Souza PA, Franco EL, Villa LL(*), Petzl-Erler ML. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiology, Biomarkers and Prevention 9: 1183-1191, 2000.

107. Villa LL(*), Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. Journal of General Virology 81, 2959–2968, 2000.

108. Ferenczy A, Franco EL. Cervical-cancer screening beyond the year 2000. Lancet Oncology 2: 27-32, 2001.

109. Bruneau J(§*), Lamothe F, Soto, J, Lachance N, Vincelette J, Vassal A, Franco E. Sex-specific determinants of HIV infection among injection drug users in Montreal. Canadian Medical Association Journal 164: 767-776, 2001.

110. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. Canadian Medical Association Journal 164: 1017-1025, 2001.

111. Rohan TE(*), Burk RD, Franco EL. Towards a reduction of the global burden of cervical cancer. Clinical Journal of Women's Health 1: 103-106, 2001.

112. Yoskovitch A(§), Frenkiel S, Franco E, Coutlée F, Nachtigal D, Rochon L. Analysis of human papillomavirus in Schneiderian papillomas as compared to chronic sinusitis and normal nasal mucosa. Journal of Otolaryngology 30: 167-172, 2001.

113. Schlecht NF(§), Pintos J, Kowalski LP, Franco EL(*).Effect of type of alcoholic beverage on the risks of upper aerodigestive tract cancers in Brazil. Cancer Causes & Control 12: 579-587, 2001.

114. Kornegay JR(*), Shepard AP, Hankins C, Franco E, Lapointe N, Richardson H, Canadian Women's HIV Study Group, Coutleé F. Nonisotopic detection of human papillomavirus dna in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay format. Journal of Clinical Microbiology 39: 3530–3536, 2001.

115. Healey SM(§), Aronson KJ, Mao Y, Schlecht NF, Mery LS, Ferenczy A, Franco EL(*). Oncogenic human papillomavirus infection and cervical lesions in aboriginal women in Nunavut, Canada. Sexually Transmitted Diseases 28: 694-700, 2001.

116. Rousseau MC(§), Pereira JS, Prado JCM, Villa LL, Rohan TE, Franco EL(*). Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. Journal of Infectious Diseases 184:1508–1517, 2001.

117. Schlecht NF(§), Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL(*). Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. Journal of the American Medical Association 286: 3106-3114, 2001.

118. Schlecht NF(§), Franco EL(*), Rohan TE, Kjær SK, Schiffman M, Moscicki AB, Duffy SW, for the MARSH International Collaborative Group. Repeatability of sexual history in longitudinal studies: determinants of reporting error at follow-up interviews. Journal of Epidemiology and Biostatistics 6: 393-407, 2001.

119. Ferenczy A(*), Franco EL. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncology 3: 11–16, 2002.

120. Brogly SB(§), Bruneau J, Lamothe F, Vincelette J, Franco EL. HIV positive notification and behaviour changes in Montreal injection drug users. AIDS Education and Prevention 14: 17-28, 2002.

121. Coutleé F(*), Gravitt P, Kornegay JR, Hankins C, Richardson H, Lapointe N, Voyer H, Canadian Women's HIV Study Group, Franco E. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. Journal of Clinical Microbiology 40: 902-907, 2002.

122. Carvalho AL(§), Pintos J, Schlecht NF, Oliveira BV, Fava AS, Curado MP, Kowalski LP, Franco EL. Predictive factors for diagnosis of advanced-stage squamous cell carcinoma of the head and neck. Archives of Otolaryngology and Head & Neck Surgery 128: 313-318, 2002.

123. Maciag PC(§), Schlecht NF, Souza PSA, Rohan TE, Franco EL, Villa LL(*). Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection. Journal of Infectious Diseases 186: 164–172, 2002.

124. Macaskill P(*), Walter SD, Irwig L, Franco EL. Assessing the gain in diagnostic performance when combining two diagnostic tests. Statistics in Medicine 21: 2527-2546, 2002.

125. Tran-Thanh D, Koushik A, Provencher D, Drouin P, Dubuc-Lissoir J, Gauthier P, Allaire G, Kornegay J, Franco E, Coutlée F(*). Detection of Human Herpes Virus type 6 DNA in precancerous lesions of the uterine cervix. Journal of Medical Virology 68: 606–610, 2002.

126. Franco EL, Duarte-Franco E, Rohan TE. Evidence-based policy recommendations on cancer screening and prevention. Cancer Detection and Prevention 26: 350-361, 2002.

127. Nishimoto IN(§), Pintos J, Schlecht NF, Torloni H, Carvalho AL, Kowalski LP, Franco EL(*). Assessment of control selection bias in a hospital-based case-control study of upper aero-digestive tract cancers. Journal of Cancer Epidemiology and Prevention (formerly J Epidemiol Biostat) 7: 131-141, 2002.

128. Schlecht NF(§), Trevisan A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL(*). Viral load as a predictor of the risk of cervical intraepithelial neoplasia. International Journal of Cancer 103: 519-524, 2003.

129. Li J(§), Rousseau MC, Franco EL, Ferenczy A(*). Is colposcopy warranted in women with external anogenital warts? Journal of Lower Genital Tract Disease 7: 22-28, 2003.

130. Tran-Thanh D, Provencher D, Koushik A, Duarte-Franco E, Kessous A, Drouin P, Wheeler C, Dubuc-Lissoir J, Gauthier P, Allaire G, Vauclair R, DiPaolo J, Gravitt P, Franco E, Coutlée F(*). Herpes Simplex Virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix. American Journal of Obstetrics & Gynecology 188: 129-134, 2003.

131. Nonnenmacher B(§*), Pintos J, Bozzetti MC, Mielzinska-Lohnas I, Lorincz AT, Ikuta N, Schwartsmann G, Villa LL, Schiller JT, Franco E. Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer. International Journal of STD & AIDS 14: 258–265, 2003.

132. Brogly S(§), Mercier C, Bruneau J(§*), Palepu A, Franco E. Towards more effective public health programming for injection drug users: development and evaluation of the injection drug user quality of life scale. Substance Use & Misuse 38: 965-992, 2003.

133. Franco EL. Primary screening of cervical cancer with human papillomavirus tests. Journal of the National Cancer Institute Monographs 31: 89-96, 2003.

134. Richardson H(§), Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, Coutlée F, Franco EL(*). The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiology, Biomarkers & Prevention 12: 485-490, 2003.

135. Rousseau MC(§), Villa LL, Costa MC, Abrahamowicz M, Rohan TE, Franco EL(*). Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytological abnormalities. Sexually Transmitted Diseases 30: 581-587, 2003.

136. Goldie SJ(*), Grima D, Kohli M, Wright TC, Weinstein M, Franco E. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. International Journal of Cancer 106: 896-904, 2003.

137. Schlecht NF(§), Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JCM, Ferenczy A, Rohan TE, Villa LL, Franco EL(*). Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. Journal of the National Cancer Institute 95: 1336-1343, 2003.

138. Ferenczy A(*), Coutlée F, Franco E, Hankins C. Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. Canadian Medical Association Journal 169: 431-434, 2003.

139. Rousseau MC(§), Abrahamowicz M, Villa LL, Costa MC, Rohan TE, Franco EL(*). Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiology, Biomarkers & Prevention 12: 1029-1037, 2003.

140. Schlecht NF(§), Platt RW, Negassa A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL(*). Modeling the time dependence of the association between human papillomavirus infection and cervical cancer precursor lesions. American Journal of Epidemiology 158: 878–886, 2003.

141. Rohan TE(*), Burk RD, Franco EL. Toward a reduction of the global burden of cervical cancer. American Journal of Obstetrics & Gynecology 189: S37-S39, 2003.

142. Giuliano AR(*), Siegel EM, Roe DJ, Ferreira S, Baggio ML, Galan L, Duarte-Franco E, Villa LL, Rohan TE, Marshall JR, Franco EL. Dietary intake and risk of persistent human papillomavirus (HPV) infection: The Ludwig-McGill HPV natural history study. Journal of Infectious Diseases 15: 1508-1516, 2003.

143. Franco E, Schlecht N, Saslow D. The epidemiology of cervical cancer. Cancer Journal 9: 348-359, 2003.

144. Monsonego J, Bosch FX, Coursaget P, Cox JT, Franco E, Frazer I, Sankaranarayanan R, Schiller J, Singer A, Wright T, Kinney W, Meijer C, Linder J. Cervical cancer control, priorities and new directions. International Journal of Cancer 108: 329-333, 2004.

145. Mahmud S(§*), Franco E, Aprikian A. Prostate cancer and use of non-steroidal anti-inflammatory drugs: Systematic review and meta-analysis. British Journal of Cancer 90: 93-99, 2004.

146. Roy MC(§), Mayrand MH, Franco EL, Arseneau J, Ferenczy A(*). Electrofulguration for low-grade squamous intraepithelial lesions of the cervix (CIN1). Journal of Lower Genital Tract Disease 8: 10-15, 2004.

147. Aho J, Kornegay JR, Healey S, Roger M, Dion F, Gaudreault D, Shepard AP, Franco EL, Coutlee F(*). Evaluation of a convenient enzyme immunoassay to assess the quality of genital specimens submitted for the detection of human papillomavirus DNA by consensus PCR. Journal of Clinical Virology 29: 127-133, 2004.

148. Koushik A(§), Platt RW, Franco EL(*). P53 codon 72 polymorphism and cervical neoplasia: A meta-analysis review. Cancer Epidemiology, Biomarkers & Prevention 13: 11-22, 2004.

149. Pinto AP(*§), Schlecht NF, Pintos J, Kaiano J, Franco EL, Crum CP, Villa LL. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. Gynecologic Oncology 92: 856-865, 2004.

150. Goldie SJ(*), Kohli M, Grima D, Weinstein M, Wright TC, Bosch FX, Franco E. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. Journal of the National Cancer Institute 96: 604-615, 2004.

151. Bruneau J(§*), Brogly SB, Tyndall MW, Lamothe F, Franco EL. Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization. Addiction 99: 727–737, 2004.

152. Vuong T(*), Franco E, Lehnert S, Lambert C, Portelance L, Nasr E, Faria S, Hay J, Larsson S, Shenouda G, Souhami L, Wong F, Freeman C. Silver leaf nylon dressing to prevent radiation dermatitis in patients undergoing chemotherapy and external beam radiotherapy to the perineum. International Journal of Radiation Oncology, Biology and Physics 59: 809-814, 2004.

153. Duarte-Franco E(*), Franco EL. Cancer of the Uterine Cervix. BMC Womens Health 4 (Suppl 1): S13 (1-10), 2004.

154. Duarte-Franco E(*), Franco EL. Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers. BMC Womens Health 4 (Suppl 1):S14 (1-9), 2004.

155. Siegel EM, Craft N, Roe D, Duarte-Franco E, Villa LL, Franco EL, Giuliano AR(*). Temporal variation and identification of factors associated with endogenous retinoic acid isomers in serum from Brazilian women. Cancer Epidemiology, Biomarkers & Prevention 13: 1693-1703, 2004.

156. Harper DM(*), Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, Dubin G; GlaxoSmithKline HPV Vaccine Study Group. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364: 1757-1765, 2004.

157. Healey SM(§*), Aronson K, Mao Y, Franco EL. Human papillomavirus and cervical dysplasia in Nunavut: prelude to a screening strategy. International Journal of Circumpolar Health. 63 Suppl 2:199-201, 2004.

158. Sichero L, Franco EL, Villa LL(*). Different p105 promoter activities among natural variants of human papillomavirus type 18. Journal of Infectious Diseases 191: 739-742, 2005.

159. Spence A(§), Franco E, Ferenczy A(*). The role of human papillomaviruses in cancer: evidence to date. American Journal of Cancer 4: 49-64, 2005.

160. Richardson H(§), Abrahamowicz M, Tellier P, Kelsall G, du Berger R, Ferenczy A, Coutlée F, Franco EL(*). Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students. Cancer Epidemiology Biomarkers & Prevention 14: 1149-1156, 2005.

161. Coutlée F(*), Rouleau D, Ferenczy A, Franco E. The laboratory diagnosis of genital human papillomavirus infections. Canadian Journal of Infectious Diseases and Medical Microbiology 16: 83-91, 2005.

162. Koushik A(§), Ghosh A, Duarte-Franco E, Forest P, Voyer H, Matlashewski G, Coutlée F, Franco EL(*), for the Biomarkers of Cervical Cancer Risk (BCCR) Study Team. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Cancer Detection and Prevention 29: 307-316, 2005.

163. Kowalski LP(§*), Nishimoto IN, Carvalho AL, Oliveira BV, Curado MP, Fava AS, Torloni H, Franco EL. Looking beyond tobacco and alcohol: The role of lifestyle and other environmental risk factors for laryngeal cancer. Applied Cancer Research 25: 10-19, 2005.

164. Vilela LD(§), Nicolau B, Mahmud S, Edgar L, Hier M, Black M, Franco EL, Allison P(*). A comparison of psychosocial outcomes in head and neck cancer patients receiving a coping strategies intervention and control subjects receiving no intervention. Journal of Otolaryngology (in press).

165. Mahmud SM (§*), Tanguay S, Bégin LR, Franco EL, Aprikian AG. Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population. European Journal of Cancer Prevention (in press).

166. Burchell AN(§),Richardson H, Mahmud SM, Trottier H, Tellier PP, Hanley J, Coutlée F, Franco EL(*). Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. American Journal of Epidemiology (in press).

167. Monsonego J(*), Pintos J, Semaille C, Beumont M, Dachez R, Zerat L, Bianchi A, Franco E. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia. International Journal of Gynecological Cancer (in press).

168. Trottier H(§), Franco EL(*). The epidemiology of genital human papillomavirus infection. Vaccine (in press).

169. Mayrand MH(§), Duarte-Franco E, Coutlée F, Rodrigues I, Walter SD, Ratnam S, Franco EL(*), for the CCCaST Study Group. Randomized study of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of The Canadian Cervical Cancer Screening Trial (CCCaST). International Journal of Cancer (in press).

PUBLICATIONS (peer-reviewed articles, authorship as part of study group)

1. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C; American Cancer Society Advisory Groups. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer Journal for Clinicians 52: 342-362, 2002.

2. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, Fernandez L, Idris A, Sanchez MJ, Nieto A, Talamini R, Tavani A, Bosch FX, Reidel U, Snijders PJ, Meijer CJ, Viscidi R, Munoz N, Franceschi S; IARC Multicenter Oral Cancer Study Group. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. Journal of the National Cancer Institute 95: 1772-1783, 2003.

PUBLICATIONS (invited editorials, non-peer-reviewed articles, letters, etc.)

1. Franco EL, Simons AR. Linear-exponential curve fitting in biology. PPC Calculator Journal 9: 14-16, 1982.

2. Camargo B(*§), Saba L, Franco E. Tumor de Wilms no Brasil. Oncologia Atual 1: 6-8, 1991.

3. Franco EL. Pautas para el tratamiento del tumor de Wilms: Invited commentary: The importance of cooperative groups in oncology. Salud y Ciencia 2: 16, 1992.

4. Franco EL. Race and gender influences on the survival of patients with mouth cancer. Invited commentary. Oncology Digest 2: 25-26, 1994.

5. Camargo B(§), Franco E. Report on the First South American Wilms' Tumor Workshop. SIOP News 9: 9, 1994.

6. Franco EL. Invited Editorial: A personal view of the epidemiological presentations in the 13th International Papillomavirus Conference, Amsterdam. Papillomavirus Report 5: 183-187, 1994.

7. Franco EL. Recent advances in the molecular epidemiology of cervical cancer. Sao Paulo Medical Journal 113 (2, suppl.): 28-29, 1995.

8. Franco EL. Invited Editorial: A personal view of the epidemiological presentations in the 14th International Papillomavirus Conference, Quebec City. Papillomavirus Report 6: 147-150, 1995.

9. Franco EL(*), Syrjänen K, De Wolf C, Patnick J, Ferenczy A, McGoogan E, Bosch X, Singer A, Muñoz N, Meheus A, Monsonego J. Meeting report: New developments in cervical cancer screening and prevention. Cancer Epidemiology, Biomarkers & Prevention 5: 853-856, 1996.

10. Latorre MR(§), Franco EL. Epidemiologia dos tumores na infância. Acta Oncologica Brasileira 16: 201-219, 1996.

11. Franco EL. Invited editorial: Understanding the epidemiology of genital infection with oncogenic and non-oncogenic human papillomaviruses: A promising lead for primary prevention of cervical cancer. Cancer Epidemiology, Biomarkers & Prevention 6: 759-761, 1997.

12. Franco EL. Invited editorial: Defining safe drinking water. Epidemiology 8: 607-609, 1997. Reprinted in Infectious Diseases in Clinical Practice 7: 63-65, 1998.

13. Richardson H(§), Franco EL(*). Human Papillomavirus infection and cervical cancer: an update. Mature Medicine Canada 1: 26-28, 1998.

14. Franco EL. Invited editorial: “A epidemiologia do câncer no Brasil: onde estamos e para onde devemos ir.” Revista da Sociedade Brasileira de Cancerologia 1: 10-13, 1998.

15. Bruneau J(*§), Lamothe F, Franco E. Letter to the Editor: Re: High rates of HIV infection among injection drug users. American Journal of Epidemiology 148: 716-717, 1998.

16. Latorre MR(§), Franco EL. Epidemiologia dos sarcomas. Acta Oncologica Brasileira 18: 3-14, 1998.

17. Franco EL. Invited editorial: “Ponto de vista: A epidemiologia do câncer no Brasil.” Revista Médicos 2: 96-100, 1999.

18. Franco EL. Invited Letter to the Editor: Being a medical scientist: it takes love and dedication to research, not a title. McGill Journal of Medicine 5: 2-3, 1999.

19. Bruneau J(*§), Franco E. Letter to the Editor: Re: High rates of HIV-1 infection among drug users participating in needle exchange programs in Montreal. American Journal of Epidemiology 150: 326, 1999.

20. Franco EL, Schlecht NF. Authors’ response to “Invited Commentary: More evidence of increased risks of cancer among alcohol drinkers. American Journal of Epidemiology 150: 1141, 1999.

21. Schlecht NF(§), Franco EL(*). Letter to the Editor: Authors’ response to “Re: Interaction between tobacco and alcohol and the risk of cancers of the upper aero-digestive tract in Brazil.” American Journal of Epidemiology 152: 193-194, 2000.

22. Sharpe CR(§), Franco EL(*). Letter to the Editor: Re: The influence of parental age on the risk of Wilms’ tumour. Paediatric and Perinatal Epidemiology 14: 284-285, 2000.

23. Bosch FX, Muñoz N, Sanjosé S, Franco EL, Lowy DR, Schiffman M, Franceschi S, Kjær S, Meijer CJLM, Frazer IH, Cuzick J. Letter to the editor Re:. Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer. Journal of the National Cancer Institute 93: 1349-1350, 2001.

24. Franco EL, Duarte-Franco E, Ferenczy A. Reply to E Ellison: Re: The merits of new alternatives to the Papanicolaou test. Canadian Medical Association Journal 165:739-40, 2001.

25. Duarte-Franco E, Franco EL(*). Determinants of patient survival in cervical cancer: an overview. CME Journal of Gynecologic Oncology 6: 173-183, 2001.

26. Mayrand MH(§), Franco EL(*). Screening elderly women for urogenital cancers: When should we stop giving older women Pap tests? Geriatrics & Aging 5: 39-42, 2002.

27. Villa LL, Amestoy G, Franco E. Introduction. Virus Research 189: 161, 2002.

28. Villa LL, Bernard HU, Kast M, Hildesheim A, Amestoy G, Franco E. Past, present, and future of HPV research: highlights from the 19th International Papillomavirus Conference-HPV2001. Virus Research 189: 163-173, 2002.

29. Gilbert L, Krishnamurthy S, Tan SL, Franco EL. Letter to the Editor Re: Estrogen replacement therapy and risk of ovarian cancer in post-menopausal women. Journal of the American Medical Association 288: 2538-2539, 2002.

30. Wolf JK, Franco EL, Arbeit JM, Shroyer KR, Wu TC, Runowicz CD, Tortolero-Luna G, Herrero R, Crum CP. Innovations in understanding the biology of cervical cancer. Cancer 98 (Suppl): 2064-2069, 2003.

31. Franco EL. Invited Commentary: Are we ready for a paradigm change in cervical cancer screening? Lancet 362: 1866-1867, 2003.

32. Franco EL, Duarte-Franco E, Ferenczy A. Prospects for controlling cervical cancer at the turn of the century. Salud Publica de Mexico 45 (suppl. 3): S367-375, 2003.

33. Franco EL. Invited Editorial: Male circumcision and AIDS in Africa: Primum non nocere versus the collective good. Epidemiology 15: 133-134, 2004.

34. Franco EL. Invited Editorial: Randomized controlled trials of hpv testing and Pap cytology: Toward evidence-based cervical cancer prevention. International Journal of Cancer 110: 1-2, 2004.

35. Mahmud S(§), Franco EL(*). Invited Editorial: An overview of epidemiologic and public health research on HPVs presented at the 21st International Papillomavirus Conference in Mexico City. Papillomavirus Report 15: 121-123, 2004.

36. Dang-Tan T(§), Mahmud S, Puntoni R, Franco EL(*). Polio vaccines, Simian Virus 40, and human cancer: The epidemiologic evidence for a causal association. Oncogene 23: 6535-6540, 2004.

37. Franco EL, Correa P, Santella RM, Wu X, Goodman SN, Petersen GM. Role and limitations of epidemiology in establishing a causal association. Seminars in Cancer Biology 14: 413-426, 2004.

38. Stuart G(*), Taylor G, Bancej CM, Beaulac J, Colgan T, Franco EL, Kropp RY, Lotocki R, Mai V, McLachlin CM, Onysko J, Martin RE. Report of the 2003 Pan-Canadian Forum on Cervical Cancer Prevention and Control. Journal of Obstetrics and Gynaecology of Canada 26: 1004-1014, 2004.

39. Franco EL, Duarte-Franco EF. Invited Commentary: Screening every three years, instead of annually, would result in a small increase in risk of cervical cancer (Sawaya et al., N Engl J Med 2003; 349:1501-1509). Evidence-Based Obstetrics & Gynecology 6: 204-205, 2004.

40. Franco EL, Harper DM. Vaccination against human papillomavirus infection: A new paradigm in cervical cancer control. Vaccine 23: 2388-2394, 2005.

41. Lau S, Franco EL(*). Management of low-grade cervical lesions in young women. Canadian Medical Association Journal 173: 771-774, 2005.

42. Franco EL. Invited Commentary: Epidemiology as a tool to reveal inequalities in breast cancer care. Public Library of Science: Medicine (in press).

43. Frazer IH(*), Cox JT, Mayeaux EJ, Franco EL, Moscicki AB, Palefsky J, Ferris D, Ferenczy A, Villa, L. Human papillomavirus infection. Pediatric Infectious Disease Journal (in press).

Books

Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell Science, Oxford, 1997, 470 pages, ISBN 0-632-04765-8 (personal authorship of individual chapters listed below).

Franco EL, Rohan TE (eds.) Cancer Precursors: Epidemiology, Detection, and Prevention. Springer-Verlag, New York, 2002, 430 pages, ISBN 0-387-95188-1 (personal authorship of individual chapters listed below).

Journal supplements

Villa LL, Amestoy G, Franco E (Guest Editors). Special Issue: 19th International Papillomavirus Conference, Florianopolis, Brazil, 1–7 September 2001. Virus Research 189: 161-314, 2002 (personal authorship of two articles listed above).

BOOK CHAPTERS AND MONOGRAPHS

1. Mirra AP, Franco EL(*). Cancer Incidence in Sao Paulo, Brazil. In: Franco EL (ed.). LICR Monograph series in Cancer Epidemiology, Vol. 1, Ludwig Institute for Cancer Research, 1985.

2. Carvalho MRC, Franco EL(*). Cancer Incidence in Recife, Brazil. In: Franco EL (ed.). LICR Monograph Series in Cancer Epidemiology, Vol. 2, Ludwig Institute for Cancer Research, 1986.

3. Mirra AP, Franco EL(*). Cancer Mortality in Sao Paulo, Brazil. In: Franco EL (ed.). LICR Monograph series in Cancer Epidemiology, Vol. 3, Ludwig Institute for Cancer Research, 1987.

4. Soto JC(*), Levy M, Allard R, Franco EL. Survey of attitudes, beliefs and knowledge related to AIDS among dental professionals in Quebec. In: Ajdukovic D (Ed.) Oral AIDS: manifestations, safety measures and questions of transmissibility. Elsevier, New York, 1990.

5. Kowalski LP(§), Franco EL(*). Epidemiologia do câncer no Brasil e no mundo. In: Schwartzmann G (ed.) Oncologia clínica: Princípios e prática. Editora Artes Medicas, Sao Paulo, 1991 (pp. 19-30).

6. Franco EL. Measurement errors in epidemiologic studies of human papillomavirus and cervical cancer. In: Muñoz N et al. (eds.) The epidemiology of human papillomavirus and cervical cancer. IARC scientific publication no. 119, Oxford University Press, Oxford, 1992 (pp. 181-197).

7. Franco EL. Rapporteur's summary and discussion: Association of HPV and anogenital cancer and implications for screening policy. In: Muñoz N et al. (eds.) The epidemiology of human papillomavirus and cervical cancer. IARC scientific publication no. 119, Oxford University Press, Oxford, 1992 (pp. 283-284).

8. Mandeville R, Mercier G, Oth D, Descoteaux JP, Lis M, Franco E, Houde M, Tremblay L. IAF chronic carcinogenicity evaluation of 60 Hz linear sinusoidal continuous wave magnetic fields in rats: Protocol outline and quality assurance program development. In: Blank M (ed.) Electricity and magnetism in biology and medicine. San Francisco Press, San Francisco, 1993 (pp. 419-422).

9. Franco EL. Epidemiologia do cancer mamario e ginecologico. In: Abrao F (ed.) Tratado de oncologia genital e mamaria. Editora Roca, Sao Paulo, 1995 (pp. 3-16).

10. Franco EL. Epidemiology of anogenital warts and cancer. In: Reid R, Lorincz A (eds.) Human Papillomaviruses I. Obstetrics and Gynecology Clinics of North America, W.B. Saunders, Philadelphia, 23: 597-623, 1996.

11. Franco EL. Epidemiology in the study of cancer. In: Bertino JR et al. (eds.), Encyclopedia of Cancer, Vol. 1. Academic Press, San Diego, 1997 (pp. 621-641).

12. Franco EL, Monsonego J. Introduction. In: Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell, Oxford, 1997 (pp. xiii-xiv).

13. Franco EL, Villa LL, Richardson H, Rohan T, Ferenczy A. Epidemiology of cervical human papillomavirus infection. In: Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell, Oxford, 1997 (pp. 14-22).

14. Franco EL. Statistical issues in studies of human papillomavirus infection and cervical cancer. In: Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell, Oxford, 1997 (pp. 39-50).

15. Ferenczy A, Franco EL. HPV DNA testing using liquid-based cytology. In: Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell, Oxford, 1997 (pp. 348-353).

16. Villa LL, Rahal P, Franco EL(*). Molecular variant analysis as a tool in natural history studies of human papillomavirus infection and cervical neoplasia. In: Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell, Oxford, 1997 (pp. 379-385).

17. Franco EL. Rapporteurs’ summary of presentations. In: Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell, Oxford, 1997 (pp. 453-461).

18. Franco EL. Highlights and consensus. In: Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell, Oxford, 1997 (pp. 462-464).

19. Franco EL. Epidemiology of uterine cancers (chapter 14). In: Meisels A, Morin C (eds.) Cytopathology of the uterus, 2nd Edition. American Society of Clinical Pathologists, Chicago, 1997 (pp. 301-324).

20. Latorre MR(§), Franco EL(*). Epidemiologia do câncer de ovário. In: Abrao F (ed.) Cancer do ovário. Editora Roca, Sao Paulo, 1997 (pp. 51-64).

21. Allison PJ(§), Franco E, Locker D, Feine JS. The role of delays and anatomical site in determining disease stage among oral and oropharyngeal cancers. In: Varma AK (ed.) Oral Oncology, Vol V, ICOC Press, New Delhi, 1997 (pp. 112-115).

22. Latorre MR(§), Franco EL(*). Epidemiologia. In: Lopes AL (ed.) Sarcomas de partes moles. MEDSI Editora, Sao Paulo, 1998 (pp. 3-18).

23. Franco EL. Statistical issues in human papillomavirus testing and screening. In: Carr J (ed.) Human Papillomavirus. Clinics in Laboratory Medicine, W.B. Saunders, Philadelphia, 2000 (pp 345-367).

24. Carvalho AL(§), Schlecht NF, Pintos J, Oliveira BV, Fava AS, Curado MP, Kowalski LP, Franco EL. Factors influencing patient and professional delay in oral cancer diagnosis. In: Varma AK, Roodenburg JLN (eds.) Oral Oncology, Vol VII, ICOC Press, The Hague, 2001 (pp. 31-34).

25. Carvalho AL(§), Pintos J, Schlecht NF, Oliveira BV, Fava AS, Curado MP, Kowalski LP, Franco EL. Incidence of second primary tumours in a cohort of head and neck cancer patients in Brazil. In: Varma AK, Roodenburg JLN (eds.) Oral Oncology, Vol VII, ICOC Press, The Hague, 2001 (pp. 72-74).

26. Rohan TE, Franco EL. Introduction. In: Franco EL, Rohan TE (eds.) Cancer Precursors: Epidemiology, Detection, and Prevention. Springer-Verlag, New York, 2002 (pp. 1-3).

27. Franco EL, Rohan TE. Assessing epidemiologic relations and the role of measurement errors. In: Franco EL, Rohan TE (eds.) Cancer Precursors: Epidemiology, Detection, and Prevention. Springer-Verlag, New York, 2002 (pp. 60-74).

28. Franco EL, Ferenczy A. Cervix. In: Franco EL, Rohan TE (eds.) Cancer Precursors: Epidemiology, Detection, and Prevention. Springer-Verlag, New York, 2002 (pp. 249-286).

29. Franco EL, Ferenczy A. Endometrium. In: Franco EL, Rohan TE (eds.) Cancer Precursors: Epidemiology, Detection, and Prevention. Springer-Verlag, New York, 2002 (pp. 287-303).

30. Franco EL, Rohan TE. Evidence-based policy recommendations on screening and prevention. In: Franco EL, Rohan TE (eds.) Cancer Precursors: Epidemiology, Detection, and Prevention. Springer-Verlag, New York, 2002 (pp. 389-403).

31. Rohan TE, Franco EL. Prospects. In: Franco EL, Rohan TE (eds.) Cancer Precursors: Epidemiology, Detection, and Prevention. Springer-Verlag, New York, 2002 (pp. 407-410).

32. Rousseau MC(§), Franco EL(*). Détection des infections à HPV. In: Aubin F, Pretet JL, Mougin C (eds.) Papillomavirus humains, biologie et pathologie tumorale. Editions Médicales Internationales, Paris, 2003 (pp. 601-626).

33. Carvalho A(§), Pintos J, Schlecht N, Oliveira B, Fava A, Curado MP, Kowalski LP, Franco EL. Age and alcohol consumption influence prognosis of head and neck cancer patients. In: Varma AK, Reade P (eds.) Oral Oncology, Vol 9, MacMillan Press, India, 2003 (pp. 101-103).

34. Tortolero-Luna G, Franco EL. Epidemiology of cervical, vulvar, and vaginal cancer: Unresolved issues and future research. In: Gershenson DM, Gore M, Quinn MJ, Thomas G (Eds.). Gynecologic cancer: Controversies in management. Elsevier Science and Churchill Livingstone (pp. 3-30), ISBN:044307142X, 2004.

35. Franco EL. The Role of Viruses in Oncogenesis: Human Papillomaviruses and Cervical Cancer as a Paradigm. In: Knobler S, O'Connor S, Lemon S (eds.). The Infectious Etiology of Chronic Diseases: Defining the Relationship, Enhancing the Research, and Mitigating the Effects. National Academy Press, Washington, D.C. 2004, pp. 17-28 (ISBN 0-309-08994-8).

36. Duarte-Franco E, Franco EL(*). Cancer of the Colon and Rectum: Epidemiology and Risk factors. In: Rossi BM (ed.) Cancer of the Colon, Rectum and Anus, Lemar and Tecmedd, Sao Paulo, 2005, pp. 3-22, ISBN 858665303-9.

37. Duarte-Franco E, Franco EL(*). Cancer of the Anus: Epidemiology and Risk Factors. In: Rossi BM (ed.) Cancer of the Colon, Rectum and Anus, Lemar and Tecmedd, Sao Paulo, 2005, pp. 665-678, ISBN 858665303-9.

38. Duarte-Franco E, Franco EL(*). Epidemiologia do cancer mamario e ginecologico. In: Abrao F (ed.) Tratado de oncologia genital e mamaria. 2a. Edição, Editora Roca, Sao Paulo (in press).

39. Koushik A(§), Franco EL(*). Epidemiology and the role of human papillomaviruses. In: Jordan, Singer, Shafi, Jones (eds.) The Cervix, 2nd Edition, Blackwell, Oxford (in press).

40. Spence A(§), Franco EL(*). Screening for cervical cancer using HPV tests. In: Jordan, Singer, Shafi, Jones (eds.) The Cervix, 2nd Edition, Blackwell, Oxford (in press).

41. Rohan TE, Henson D, Franco EL, Albores-Saavedra J. Cancer Precursors. In: Schottenfeld D, Fraumeni J (eds.) Cancer Epidemiology and Prevention, 3rd edition, Oxford, in press.

42. Spence A(§), Franco EL(*). Epidemiology of uterine cancers. In: Meisels A, Morin C (eds.) Cytopathology of the uterus, 3rd Edition. American Society of Clinical Pathologists, Chicago, in press.

43. Mayrand MH(§), Franco EL(*). Prevention of uterine cancers. In: Meisels A, Morin C (eds.) Cytopathology of the uterus, 3rd Edition. American Society of Clinical Pathologists, Chicago, in press.